TW200621281A - Cerebral fatigue recovery agent - Google Patents

Cerebral fatigue recovery agent

Info

Publication number
TW200621281A
TW200621281A TW094139278A TW94139278A TW200621281A TW 200621281 A TW200621281 A TW 200621281A TW 094139278 A TW094139278 A TW 094139278A TW 94139278 A TW94139278 A TW 94139278A TW 200621281 A TW200621281 A TW 200621281A
Authority
TW
Taiwan
Prior art keywords
fatigue recovery
cerebral
recovery agent
cerebral fatigue
acids
Prior art date
Application number
TW094139278A
Other languages
English (en)
Chinese (zh)
Inventor
Hidetoshi Sadachi
Yoshinao Nagashima
Takuya Watanabe
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of TW200621281A publication Critical patent/TW200621281A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
TW094139278A 2004-11-09 2005-11-09 Cerebral fatigue recovery agent TW200621281A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004324516 2004-11-09
JP2005048198A JP2006160721A (ja) 2004-11-09 2005-02-24 大脳疲労回復剤

Publications (1)

Publication Number Publication Date
TW200621281A true TW200621281A (en) 2006-07-01

Family

ID=36336452

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094139278A TW200621281A (en) 2004-11-09 2005-11-09 Cerebral fatigue recovery agent

Country Status (6)

Country Link
US (2) US20070270497A1 (enExample)
EP (1) EP1810671A4 (enExample)
JP (1) JP2006160721A (enExample)
KR (1) KR20070083944A (enExample)
TW (1) TW200621281A (enExample)
WO (1) WO2006051773A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115067450A (zh) * 2022-05-24 2022-09-20 广东橘香斋大健康产业股份有限公司 一种营养补充型抗疲劳固体饮料及其制备方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034410B2 (en) 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
TW201733619A (zh) * 2015-12-16 2017-10-01 Suntory Holdings Ltd 肌肽二肽酶阻礙用組成物
JP2018039797A (ja) * 2016-09-02 2018-03-15 花王株式会社 脳機能改善剤
CN111758841B (zh) * 2020-08-19 2023-07-28 上海俏贝丽宠物用品有限公司 促进幼犬猫智力发育的组合物、添加剂、保健品及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3924017A (en) * 1972-07-28 1975-12-02 Gen Foods Corp Sweetness inducer
US3916028A (en) * 1972-07-28 1975-10-28 Gen Foods Corp Sweetness inducer
US4145255A (en) * 1977-02-25 1979-03-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Method and device for the detection of phenol and related compounds
DE3603576A1 (de) * 1986-02-06 1987-08-13 Code Kaffee Handel Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz
DE3603574C1 (de) * 1986-02-06 1987-07-23 Ergo Forschungsgmbh Verfahren zur Gewinnung von Chlorogensaeure
JPS62277326A (ja) * 1986-05-24 1987-12-02 Zeria Shinyaku Kogyo Kk 脳機能改善剤
WO2004073726A1 (ja) * 1993-10-21 2004-09-02 Keiichi Togasaki 活性酸素フリーラジカル消去剤
US5958417A (en) * 1996-10-24 1999-09-28 Hsu; Chau-Shin Herbal combinations
JP4210364B2 (ja) * 1998-04-22 2009-01-14 花王株式会社 自律神経機能向上剤及び食品
US6458392B1 (en) * 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension
JP3548102B2 (ja) * 2000-08-07 2004-07-28 花王株式会社 高血圧症予防・治療剤
US6991812B2 (en) * 2000-09-05 2006-01-31 Kao Corporation Agent for preventing, improving or treating hypertension
JP4077149B2 (ja) * 2000-11-02 2008-04-16 花王株式会社 自律神経機能向上剤
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
ITMI20022389A1 (it) * 2002-11-12 2004-05-13 Nicox Sa Farmaci per le disfunzioni sessuali.
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115067450A (zh) * 2022-05-24 2022-09-20 广东橘香斋大健康产业股份有限公司 一种营养补充型抗疲劳固体饮料及其制备方法

Also Published As

Publication number Publication date
EP1810671A1 (en) 2007-07-25
US20090264524A1 (en) 2009-10-22
EP1810671A4 (en) 2010-10-13
KR20070083944A (ko) 2007-08-24
WO2006051773A1 (ja) 2006-05-18
US20070270497A1 (en) 2007-11-22
JP2006160721A (ja) 2006-06-22

Similar Documents

Publication Publication Date Title
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2008088030A1 (ja) 血栓もしくは塞栓に関連する疾患の予防又は治療用組成物
WO2008070670A3 (en) Enhanced immediate release formulations of topiramate
WO2005000332A3 (en) Therapeutic agent for soft tissue sarcoma
WO2007019251A3 (en) Sphingosine kinase inhibitors and methods of their use
WO2009039460A3 (en) Co-administration of pimavanserin with other agents
EP1283058A4 (en) AGENTS FOR PREVENTING OR IMPROVING INSULIN RESISTANCE AND / OR OBESITY
WO2000077206A3 (en) The myostatin gene promoter and inhibition of activation thereof
WO2009108383A3 (en) Substituted xanthine derivatives
WO2010111640A3 (en) Anti-influenza formulations and methods
ZA200806778B (en) N-Hydroxyacrylamide compounds
WO2010009120A8 (en) Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
WO2004073623A3 (en) Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
WO2011126250A3 (ko) Pde5 억제제를 함유하는 피부 주름 개선용 조성물
WO2011017054A3 (en) Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
WO2008064202A3 (en) Modified-release formulations of calcium receptor-active compounds
WO2011140232A3 (en) Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
TW200731974A (en) Transdermal system for verenicline
WO2008016640A3 (en) Use of poloxamer for the prevention and/or treatment of heart failure
MX2007003196A (es) Agente y alimento para evitar/mejorar el trastorno digestivo funcional.
TW200621281A (en) Cerebral fatigue recovery agent
WO2008153318A3 (en) Transglutaminase inhibitor comprising chlorogenic acid and a method for producing thereof
TW200716184A (en) Inhibitor for parakeratosis, pore reducing agent or skin roughening preventing or ameliorating agent and composition for skin care preparation
DK1954251T3 (da) Sammensætning med langvarig frigivelse, som har jernsalt som aktiv bestanddel, fremgangsmåde til fremstilling deraf og anvendelse deraf
WO2006053184A3 (en) Methods for treating or preventing a vascular disease